Quotes Celldex Therapeutics, Inc. London S.E.
Stocks
0HUU
US15117B2025
Biotechnology & Medical Research
|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 09-22 | Top Midday Decliners | MT |
| 09-22 | Celldex Therapeutics, Inc. - Special Call |
Stock exchange
London S.E.
0HUU - $
-.--%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| CLDX | 31.49USD | +1.25% | 57.45M $ | ||
CBOE
| CLDX | 31.49USD | +1.22% | 1.25M $ | |
|
Tradegate
| TCE2 | 27.72EUR | +1.58% | 25.5K € | |
|
Boerse Muenchen
| TCE2 | 27.88EUR | +2.50% | 4.57K € | |
|
Börse Stuttgart
| TCE2 | 27.52EUR | +0.84% | 0 € | |
|
Deutsche Boerse AG
| TCE2 | 26.76EUR | -1.94% | 0 € | |
|
Berne S.E.
| TCE1 | 26.06CHF | +1.40% | 0 CHF |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
2,442,268,445
Net sales (USD)
1,545,000
Free-Float
99.73%
Free-Float capitalization (USD)
2,435,657,736
Indicators
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.44B | |
| +2.64% | +6.45% | +11.87% | +38.40% | 47.97B | |
| +0.22% | +0.40% | +50.91% | +37.06% | 44.5B | |
| -1.58% | +4.66% | +359.34% | +614.38% | 43.93B | |
| +1.70% | +0.36% | +12.56% | +99.27% | 41.03B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.85B | |
| -0.48% | -1.32% | +23.98% | +150.01% | 17.27B | |
| +0.08% | +9.03% | +8.41% | - | 15.34B | |
| +1.76% | +0.85% | +29.13% | +48.42% | 15.3B | |
| +1.97% | -3.17% | - | - | 14.82B | |
| Average | +0.76% | +1.63% | +62.67% | +147.77% | 27.25B | |
| Weighted average by Cap. | +0.74% | +1.89% | +79.47% | +163.79% |
Historical Quotes: Celldex Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- CLDX Stock
- 0HUU Stock
- Quotes Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
